EUVIMEDEUVIMED entdecken
Crossref

Évaluation du prix des médicaments figurant sur les bulletins officiels au Maroc (2014–2019)

Fatima Zahra Bimegdi, Abdelmajid Belaiche, Samir Ahid

Annales Pharmaceutiques Françaises · 2023-11 · 81 (6) · 1090-1098

DOI: 10.1016/j.pharma.2023.07.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annales Pharmaceutiques Françaises, 2023-11. Verfasst von Fatima Zahra Bimegdi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Équipe de recherche de pharmaco économie et pharmaco épidémiologie, laboratoire de pharmacologie et de toxicologie, faculté de médecine et de pharmac…. Hauptthemen laut MEDLINE: Drug Costs. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: This study shows the evolution of medicines prices over the period April 2014 to September 2019 in order to provide an overview of the situation following the adoption of the new method for setting drug prices in Morocco. METHODS: The analysis concerned official bulletins relating to the Public Selling Price of drugs in Morocco published between April 2014 and September 2019 as part of a retrospective study. RESULTS: Out of a total of 7292 medicines, 35.9% were unchanged in price, 26.2% were new and 0.3% had a price increase. The decrease affected 37.7% equivalent to 2747 medicines. Of these, 38.6% decreased in price in 2014 and 84.13% had only one decrease. Medicines with a retail price of between 5 and 10 Euros were the most affected by the decrease. Decreases of less than 1% of the selling price represented 27.7% against 0.3% whose decrease exceeded 70% of the price. The largest decreases in number were recorded in 2014. Some medicines saw declines of up to 78.6%. The most affected price brackets in percentage terms were those with a retail price above 20 Euros. CONCLUSIONS: Following the adoption of the new decree on the pricing of medicines in 2013 in Morocco, several decreases were recorded and concerned all therapeutic classes. The percentages of the decreases in Moroccan Dirham as well as in percentage were very variable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug CostsMoroccoRetrospective StudiesHumansCommercePharmaceutical Preparations

Stichwörter der Autor:innen

Baisse de prixFixation de prixMOROCCOMarocMedicines pricePrice dropPrice fixingPrix du médicament

Substanzen

Pharmaceutical Preparations

Autor:innen und Institutionen

  • Équipe de recherche de pharmaco économie et pharmaco épidémiologie, laboratoire de pharmacologie et de toxicologie, faculté de médecine et de pharmacie, université Mohamed V, Rabat, Maroc. Electronic address: bimegdi@ya…
  • Équipe de recherche de pharmaco économie et pharmaco épidémiologie, laboratoire de pharmacologie et de toxicologie, faculté de médecine et de pharmacie, université Mohamed V, Rabat, Maroc.
  • Équipe de recherche de pharmaco économie et pharmaco épidémiologie, laboratoire de pharmacologie et de toxicologie, faculté de médecine et de pharmacie, université Mohamed V, Rabat, Maroc; Euromed Research Center, Eurom…

Zitieren

APA

Bimegdi, F. Z., Belaiche, A., & Ahid, S. (2023). Évaluation du prix des médicaments figurant sur les bulletins officiels au Maroc (2014–2019). Annales Pharmaceutiques Françaises, 81(6), 1090-1098. https://doi.org/10.1016/j.pharma.2023.07.006

Vancouver

Bimegdi FZ, Belaiche A, Ahid S. Évaluation du prix des médicaments figurant sur les bulletins officiels au Maroc (2014–2019). Annales Pharmaceutiques Françaises. 2023;81(6):1090-1098. doi:10.1016/j.pharma.2023.07.006

BibTeX
@article{Bimegdi2023,
  author = {Bimegdi, Fatima Zahra and Belaiche, Abdelmajid and Ahid, Samir},
  title = {Évaluation du prix des médicaments figurant sur les bulletins officiels au Maroc (2014–2019)},
  journal = {Annales Pharmaceutiques Françaises},
  year = {2023},
  volume = {81},
  number = {6},
  pages = {1090--1098},
  doi = {10.1016/j.pharma.2023.07.006}
}
Kostenlos starten →